Science Market Update

Texas A&M Awarded $9 M in Cancer Research Funding from CPRIT

Posted by Rebecca Inch-Partridge on Wed, Sep 26, 2018

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded more than $9 million in research grants to Texas A&M University. Of the $9,057,870 in funding from CPRIT, more than $7.7 million is for academic research and $1.35 million is for a prevention grant. Eight grants were awarded by CPRIT. The largest was $5,793,075 to the recently established Center for Advanced Microscopy and Image Informatics (CAMII) in the Institute of Biosciences and Technology, College of Medicine.  

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, BioResearch Product Faire, laboratory suppliers, cancer research grant, cancer researchers, colon cancer, medical marijuana

Biomedical News: Charlie’s Law Opens Opportunities for Stem Cell Treatments in Texas

Posted by Rebecca Inch-Partridge on Thu, Nov 02, 2017

In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, pollution, BioResearch Product Faire, laboratory suppliers, Texas Medical Center, tmc, Human Stem Cell, Stem cell research, Biomedical Reearch

Texas A&M: $10M in Research Funding to Study Effects of Harvey

Posted by Rebecca Inch-Partridge on Fri, Oct 13, 2017

In the aftermath of Hurricane Harvey, a group of researchers will study the effects of the pollution stirred up by the flooding. Scientists from Texas A&M, College Station will conduct four environmental research projects thanks to a five year, $10 million grant from the National Institute of Environmental Health Sciences (NIEHS) Superfund Research Program. All four projects will stem from a case study of Galveston Bay and the Houston Ship Channel that examines the chemicals found within the sediment. These studies are designed to improve our understanding of the complexities of hazardous chemicals exposure and its negative impacts on health.   

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, environmental contaminants, pollution, BioResearch Product Faire, laboratory suppliers

Two New Mass Spectrometers Make Texas A&M a Top Facility for Studying Isotopes

Posted by Rebecca Partridge on Thu, Jan 19, 2017

The chancellor’s office of Texas A&M University (TAMU) recently funded a $5 million initiative to support mass spectrometry research. As part of this initiative a $1 million grant from the Texas A&M University Research Development Fund will be used to develop a shared mass spectrometry core facility and buy two new mass spectrometers for the College Station campus. One will be a gas chromatography combustion/pyrolysis isotope ratio mass spectrometer and the other will be a high resolution isotope ratio mass spectrometer for clumped isotopes.

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair

Texas A&M: 3D Printed Bone the Future of Facial Surgery

Posted by Rebecca Partridge on Wed, Jan 11, 2017

Currently, doctors have two options when a patient needs a facial bone replaced due to injury or illness, such as cancer. They can take a bone from another part of the body and graft it into place. However, implant morbidity and complications caused by the trauma of multiple surgeries make this option less than ideal. The second option is to graft synthetic materials to the site. However, from time of injury to delivery of the custom implant takes about three to four weeks, which reduces the chances of the patient healing properly. But now a new technology being developed by researchers at Texas A&M’s College of Dentistry may revolutionize the treatment process.  

Read More

Tags: Texas A&M, Texas A&M Research, Texas A&M University, Texas A&M Life Science Funding, biomedical researh, Biomedical Equipment, 3D printing, Biotechnology trade show, Biotechnology Vendor Fair

TAMU Wins $14M in USDA Grants for Bovine Disease and Feed Research

Posted by Jaimee Saliba on Fri, Dec 07, 2012

For both dairy and beef production, cows are an important part of the US economy and food supply. When they get sick, it's bad for business (and not too pleasant for the cow). The most common illness in cattle is Bovine Respiratory Disease (BRD), which accounts for losses of more than $690M annually in the US alone. To combat this threat to bovine health and productivity, the USDA has recently awarded a $9M 5-year grant to researchers at Texas A&M University's College of Veterinary Medicine and Biomedical Sciences, in collaboration with colleagues at the University of Missouri, to study genetic selection for breeding more disease-resitant stock. A second $5M grant will go towards research into feed efficiency, again with the aim of breeding heartier, healthier, and more profitable animals.

Read More

Tags: Southwest, animal science, Genomics, Texas, Texas A&M University, Texas A&M, 2012, Genetics, veterinary medicine, TAMU, Texas A&M Research, College Station, BioResearch Product Faire Event

Texas A&M Research Finds Vegetable Compounds Effective In Treating Breast Cancer

Posted by BCI Staff on Wed, Oct 31, 2012

Often growing up as a child you hear, “eat your veggies if you want to grow up to be big and strong.” With new research on triple negative breast cancer, that old saying might have to change to "eat your veggies if you want to keep cancer away". Recently, at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Mandip Sachdeva announced: "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer. These compounds are safer for the patient than current treatments available".

Read More

Tags: cancer research, cancer research, Texas, Texas A&M University, Bioscience research, Texas A&M, Cancer, Cancer Treatment, TX, 2012, Texas A&M Life Science Funding, Texas A&M Research, Cancer, College Station, BioResearch Product Faire Event

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News